Probiotics for women has scope to extend beyond core health areas, Lumina Intelligence predicts

By Will Chu

- Last updated on GMT

Getty | Chombosan
Getty | Chombosan
Probiotics for women’s health are making solid inroads backed by robust science, according to a new report, which also identifies breast health and osteoporosis as potential break out areas.
Osteoporosis
In the UK, the National Health Service (NHS) estimates premature menopause occurs in one out of 100 women. ©iStock.

These observations form the basis of a new report​ by Lumina Intelligence, which discusses possible directions this market may head towards, propelled by growing scientific backing and product development.

The report states the discovery of new microbiome communities on the human body means the emergence of products addressing breast health and osteoporosis are not so far-fetched.

“Science is building linking probiotics and osteoporosis benefits,”​ says report author and Lumina analyst Emer Mackle.

“Osteoporosis is critical for women as up to 20% of Bone Mass Density can be lost in the 5-7 years post-menopause. Probiotics are a potential value added ingredient to boost bone health post-menopause.

“Also, there are several menopausal symptoms including the most commonly known – hot flushes.  Relieving the lesser-known symptoms like recurring UTIs and vaginal dryness offers probiotics an avenue to establish themselves against vitamins, minerals and herbals.”

1.4 billion women

These emerging areas join the more established female-specific probiotic products for vaginal health, urinary tract infections, pregnancy and skin health in forming a market with a potential audience of more than 1.4 billion women.

Key to its growth is much to do with women’s traditional role as ‘health gatekeepers’ in many family structures, with the internet a valuable information source.

Google Trends data on the term ‘probiotics for women’ shows a 6x rise in popularity globally in the past five years, with significant spikes after 2016.

The report also finds the most search traffic emanating in the US, the UK, Canada and Australia with phrases like ‘pH balance’ referring to vaginal health also seeing an increase in searches.

The report: ‘Probiotics & Women’s Health,’ specifically identifies pregnancy as a key growth area, in which women usually pay more attention to their diet during and before pregnancy.

“Supplements such as folic acid and iron are very popular and marketed directly to pregnant women, and so it is with probiotics,”​ the report adds.

“Ailments like UTIs and bacterial vaginosis occur more frequently during pregnancy and can cause complications such as Pelvic Inflammatory Disease and increased risk of miscarriage or premature labour.

“Also, if women are using In Vitro Fertilisation (IVF) and bacterial vaginosis occurs they may increase the likelihood of having a miscarriage.”

Product analysis

Culturelle
Culturelle Women’s Healthy Balance uses Astarte probiotic strains.©CulturelleHCP.

Product-wise the report highlights Culturelle Women’s Healthy Balance as the most popular pregnancy probiotic having amassed over 800 reviews and a rating of 4.2/5.

The product uses Astarte probiotic strains taken directly from the vaginas of healthy pregnant women.

Products mentioned for breast health include ‘Garden Of Life Raw Probiotics Women 50 & Wise,’ ‘Vitafair High dosage Indol-3-Carbinol,’ ‘Lactanza Hereditum,’ and ‘Nutralactis Maternal.’

The report adds that studies suggest probiotics can be an alternative to antibiotics for mastitis relief with increasing work undertaken to aid understanding of the breast microbiome.  

“A potential target market of 1bn women who may be susceptible to these health concerns, with many more interested in ‘natural’ alternatives to medical system drugs,”​ the report concludes.

“There is massive potential for growth in all markets, especially where online consumer engagement is very low to non-existent in all countries except the US and China.”

Related news

Show more

Related products

show more

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Related suppliers

Follow us

Products

View more

Webinars